In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling BPC 157: The peptide with big claims and scant evidence STAT Taking unapproved drugs such as TB 500 and BPC 157 means:, Using DoD prohibited substances, Compromising your readiness to serve, Risking your health and military career, #LetsTalkSupplements